4
Changes in Ownership
Yarrow Bioscience, Inc. Filed Acc 0001209191-20-020935
Chief Financial Officer acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Saik Andrew · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-03-23 | Grant or award : show line 1 in the form | +50,000 | 50,000 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-03-23 | Grant or award : show line 2 in the form Stock Options | +100,000 | $3.13 | 2030-03-23 | 100,000 | 100,000 | D |
Loading xslF345X03/doc4.xml…